title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
79 Biggest Movers From Yesterday,20220608T080800,https://www.benzinga.com/news/22/06/27602286/79-biggest-movers-from-yesterday,BMEA,0.060168,Neutral,0.001703
Stocks That Hit 52-Week Lows On Monday,20220328T154408,https://www.benzinga.com/news/22/03/26326033/stocks-that-hit-52-week-lows-on-monday,BMEA,0.016131,Neutral,0.001323
Stocks That Hit 52-Week Lows On Thursday,20220421T175401,https://www.benzinga.com/markets/options/22/04/26742233/52-weeks-high-and-low-article,BMEA,0.021637,Neutral,-0.001906
"Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket - African Agriculture Hldgs  ( NASDAQ:AAGR ) , AcelRx Pharmaceuticals  ( NASDAQ:ACRX ) ",20231211T125928,https://www.benzinga.com/news/23/12/36174622/why-green-giant-shares-are-trading-lower-by-around-37-here-are-20-stocks-moving-premarket,BMEA,0.210579,Neutral,0.063397
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,BMEA,0.041466,Neutral,0.013857
Stocks That Hit 52-Week Lows On Friday,20220422T162629,https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article,BMEA,0.012589,Neutral,0.004559
